"I don’t recall seeing the word rival used previously, but the companies are indeed rivals with respect to generic Lovenox insofar as both have ANDA’s pending."
My interest in the characterization is that the press (for what it's worth) is legitimizing a co. 1/100 the size of TEVA by calling it a rival. N'est-ce pas?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.